June 22, 2020 / 6:55 PM / 15 days ago

BRIEF-Viralclear Partners With Catalent On Potential Treatment For COVID-19

June 22 (Reuters) - Biosig Technologies Inc:

* VIRALCLEAR PARTNERS WITH CATALENT ON POTENTIAL TREATMENT FOR COVID-19

* BIOSIG TECHNOLOGIES - UNDER TERMS OF AGREEMENT, CATALENT TO DEVELOP 2 ORAL DOSAGE FORMS OF VIRALCLEAR’S BROAD-SPECTRUM ANTI-VIRAL AGENT, MERIMEPODIB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below